$CLBS News Article - Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal Clinical Trial of CLBS14 in No-option Refractory Disabling Angina
https://marketwirenews.com/news-releases/cala...83055.html